Languages
English
German
French
Big 3 Consulting (MBB)
Top Consulting Firms
Experience
Silver Hill Partners LLC
Management Consulting
Principal
10/2005 - Present
• Strategy and business consulting for life sciences companies and institutions
• Pipeline & Portfolio Performance Analysis for largest Bay Area biotech company
• Developed lifecycle management playbook, tools and training for deployment across all product teams for largest independent biopharmaceutical company
• Developed biosimilar analysis and strategic organizational options, including launch plan for largest independent biopharmaceutical company
• Pipeline & Portfolio Performance Analysis for largest Bay Area biotech company
• Developed lifecycle management playbook, tools and training for deployment across all product teams for largest independent biopharmaceutical company
• Developed biosimilar analysis and strategic organizational options, including launch plan for largest independent biopharmaceutical company
Hambrecht & Quist (JP Morgan)
Finance
Associate Director
8/1999 - 2/2000
• Launched two successful European biotech IPOs, provided due diligence,
prospectus drafting, valuation and joint project management
• Led German and Scandinavian biotechnology sector research team and primary business
• Post-merger integration and business expansion for the biotechnology equities franchise of H&Q in Europe; developed corporate and market entry strategy
prospectus drafting, valuation and joint project management
• Led German and Scandinavian biotechnology sector research team and primary business
• Post-merger integration and business expansion for the biotechnology equities franchise of H&Q in Europe; developed corporate and market entry strategy
McKinsey & Company
Management Consulting
Practice Consultant
3/1998 - 7/1999
• Designed and implemented $70 MM biotechnology venture capital fund in co-operation with a large life science company; Fund is invested in 11 companies
• Performed valuations for a major drug companies’ development portfolio to determine strategies for emerging market opportunities, off-patent scenarios and merger
• Designed the set-up, business development and negotiation of the
seed financing for a functional genomics company
• Prepared merger and acquisition strategies report
• Performed valuations for a major drug companies’ development portfolio to determine strategies for emerging market opportunities, off-patent scenarios and merger
• Designed the set-up, business development and negotiation of the
seed financing for a functional genomics company
• Prepared merger and acquisition strategies report
Prognos AG
Management Consulting
Project Manager
2/1996 - 2/1998
• Designed, raised and implemented $10 MM regional seed venture capital fund (BioM AG) financed by the Bavarian Government, Aventis, Roche Diagnostics, and a banking and VC consortium
• Guided and co-authored Bavarian application for the Federal BioRegio competition, securing $30 MM grant award
• Counseled German state, federal agencies and industry clients in biotech projects
• Guided and co-authored Bavarian application for the Federal BioRegio competition, securing $30 MM grant award
• Counseled German state, federal agencies and industry clients in biotech projects